S&P 500
(0.51%) 5 214.08 points
Dow Jones
(0.85%) 39 388 points
Nasdaq
(0.27%) 16 346 points
Oil
(0.49%) $79.65
Gas
(0.43%) $2.31
Gold
(0.59%) $2 354.10
Silver
(0.83%) $28.60
Platinum
(0.22%) $993.00
USD/EUR
(0.01%) $0.927
USD/NOK
(-0.15%) $10.85
USD/GBP
(-0.01%) $0.798
USD/RUB
(0.02%) $92.56

实时更新: Cybin Inc. [CYBN]

交易所: AMEX 部门: Healthcare 工业: Biotechnology
最后更新时间10 May 2024 @ 04:00

1.03% $ 0.374

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 04:00):

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation...

Stats
今日成交量 1.50M
平均成交量 5.29M
市值 283.97M
EPS $0 ( 2024-02-13 )
下一个收益日期 ( $-0.0300 ) 2024-06-25
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.700
ATR14 $0.00200 (0.54%)

音量 相关性

長: -0.25 (neutral)
短: 0.73 (moderate)
Signal:(41.614) Neutral

Cybin Inc. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Cybin Inc. 相关性 - 货币/商品

The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.42
( neutral )

Cybin Inc. 财务报表

Annual 2022
营收: $0
毛利润: $-251 000 (0.00 %)
EPS: $-0.220
FY 2022
营收: $0
毛利润: $-251 000 (0.00 %)
EPS: $-0.220
FY 2022
营收: $0
毛利润: $0 (0.00 %)
EPS: $-0.430
FY 2021
营收: $864 000
毛利润: $200 000 (23.15 %)
EPS: $-0.320

Financial Reports:

No articles found.

Cybin Inc.

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。